591 related articles for article (PubMed ID: 10825125)
1. Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on beta-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells.
Glinsky VV; Huflejt ME; Glinsky GV; Deutscher SL; Quinn TP
Cancer Res; 2000 May; 60(10):2584-8. PubMed ID: 10825125
[TBL] [Abstract][Full Text] [Related]
2. Peptides specific to the galectin-3 carbohydrate recognition domain inhibit metastasis-associated cancer cell adhesion.
Zou J; Glinsky VV; Landon LA; Matthews L; Deutscher SL
Carcinogenesis; 2005 Feb; 26(2):309-18. PubMed ID: 15528216
[TBL] [Abstract][Full Text] [Related]
3. Characterization of peptides that bind the tumor-associated Thomsen-Friedenreich antigen selected from bacteriophage display libraries.
Peletskaya EN; Glinsky VV; Glinsky GV; Deutscher SL; Quinn TP
J Mol Biol; 1997 Jul; 270(3):374-84. PubMed ID: 9237904
[TBL] [Abstract][Full Text] [Related]
4. Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium.
Glinsky VV; Glinsky GV; Glinskii OV; Huxley VH; Turk JR; Mossine VV; Deutscher SL; Pienta KJ; Quinn TP
Cancer Res; 2003 Jul; 63(13):3805-11. PubMed ID: 12839977
[TBL] [Abstract][Full Text] [Related]
5. The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium.
Glinsky VV; Glinsky GV; Rittenhouse-Olson K; Huflejt ME; Glinskii OV; Deutscher SL; Quinn TP
Cancer Res; 2001 Jun; 61(12):4851-7. PubMed ID: 11406562
[TBL] [Abstract][Full Text] [Related]
6. MDA-MB-435 human breast carcinoma cell homo- and heterotypic adhesion under flow conditions is mediated in part by Thomsen-Friedenreich antigen-galectin-3 interactions.
Khaldoyanidi SK; Glinsky VV; Sikora L; Glinskii AB; Mossine VV; Quinn TP; Glinsky GV; Sriramarao P
J Biol Chem; 2003 Feb; 278(6):4127-34. PubMed ID: 12438311
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines.
Glinsky GV; Price JE; Glinsky VV; Mossine VV; Kiriakova G; Metcalf JB
Cancer Res; 1996 Dec; 56(23):5319-24. PubMed ID: 8968076
[TBL] [Abstract][Full Text] [Related]
8. Concomitant increases in galectin-1 and its glycoconjugate ligands (carcinoembryonic antigen, lamp-1, and lamp-2) in cultured human colon carcinoma cells by sodium butyrate.
Ohannesian DW; Lotan D; Lotan R
Cancer Res; 1994 Nov; 54(22):5992-6000. PubMed ID: 7954433
[TBL] [Abstract][Full Text] [Related]
9. Galectins as markers of aggressiveness of mouse mammary carcinoma: towards a lectin target therapy of human breast cancer.
Moiseeva EV; Rapoport EM; Bovin NV; Miroshnikov AI; Chaadaeva AV; Krasilshschikova MS; Bojenko VK; Bijleveld C; van Dijk JE; Den Otter W
Breast Cancer Res Treat; 2005 Jun; 91(3):227-41. PubMed ID: 15952056
[TBL] [Abstract][Full Text] [Related]
10. Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer.
Irie A; Yamauchi A; Kontani K; Kihara M; Liu D; Shirato Y; Seki M; Nishi N; Nakamura T; Yokomise H; Hirashima M
Clin Cancer Res; 2005 Apr; 11(8):2962-8. PubMed ID: 15837748
[TBL] [Abstract][Full Text] [Related]
11. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
[TBL] [Abstract][Full Text] [Related]
12. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
Kang H; Mansel RE; Jiang WG
Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
[TBL] [Abstract][Full Text] [Related]
13. Inositol hexaphosphate (IP6) inhibits key events of cancer metastasis: I. In vitro studies of adhesion, migration and invasion of MDA-MB 231 human breast cancer cells.
Tantivejkul K; Vucenik I; Shamsuddin AM
Anticancer Res; 2003; 23(5A):3671-9. PubMed ID: 14666663
[TBL] [Abstract][Full Text] [Related]
14. CD44 cross-linking induces integrin-mediated adhesion and transendothelial migration in breast cancer cell line by up-regulation of LFA-1 (alpha L beta2) and VLA-4 (alpha4beta1).
Wang HS; Hung Y; Su CH; Peng ST; Guo YJ; Lai MC; Liu CY; Hsu JW
Exp Cell Res; 2005 Mar; 304(1):116-26. PubMed ID: 15707579
[TBL] [Abstract][Full Text] [Related]
15. Negative cooperativity between alpha 3 beta 1 and alpha 2 beta 1 integrins in human mammary carcinoma MDA MB 231 cells.
Lichtner RB; Howlett AR; Lerch M; Xuan JA; Brink J; Langton-Webster B; Schneider MR
Exp Cell Res; 1998 May; 240(2):368-76. PubMed ID: 9597010
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of resistin-13-peptide on the proliferation, adhesion, and invasion of MDA-MB-231 in human breast carcinoma cells.
Pan B; Zhao MH; Chen Z; Lu L; Wang Y; Shi DW; Han PZ
Endocr Relat Cancer; 2007 Dec; 14(4):1063-71. PubMed ID: 18045957
[TBL] [Abstract][Full Text] [Related]
17. Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices.
Nobumoto A; Nagahara K; Oomizu S; Katoh S; Nishi N; Takeshita K; Niki T; Tominaga A; Yamauchi A; Hirashima M
Glycobiology; 2008 Sep; 18(9):735-44. PubMed ID: 18579572
[TBL] [Abstract][Full Text] [Related]
18. Tanshinone I suppresses growth and invasion of human breast cancer cells, MDA-MB-231, through regulation of adhesion molecules.
Nizamutdinova IT; Lee GW; Lee JS; Cho MK; Son KH; Jeon SJ; Kang SS; Kim YS; Lee JH; Seo HG; Chang KC; Kim HJ
Carcinogenesis; 2008 Oct; 29(10):1885-92. PubMed ID: 18586687
[TBL] [Abstract][Full Text] [Related]
19. Serum galectin-2, -4, and -8 are greatly increased in colon and breast cancer patients and promote cancer cell adhesion to blood vascular endothelium.
Barrow H; Guo X; Wandall HH; Pedersen JW; Fu B; Zhao Q; Chen C; Rhodes JM; Yu LG
Clin Cancer Res; 2011 Nov; 17(22):7035-46. PubMed ID: 21933892
[TBL] [Abstract][Full Text] [Related]
20. Carcinoembryonic antigen and other glycoconjugates act as ligands for galectin-3 in human colon carcinoma cells.
Ohannesian DW; Lotan D; Thomas P; Jessup JM; Fukuda M; Gabius HJ; Lotan R
Cancer Res; 1995 May; 55(10):2191-9. PubMed ID: 7743523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
